AngioDynamics SG&A Expense (TTM) Trends | YCharts

AngioDynamics, Inc. (ANGO)

15.20 -0.27 (-1.75%) USD | NASDAQ | Sep 04, 16:00

15.18 -0.02 (-0.13%) After-Hours: 20:00

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for ANGO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (TTM) Chart

Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2001. Start Trial.

Date	Value
May 31, 2026	157.09M
February 28, 2026	152.38M
November 30, 2025	150.21M
August 31, 2025	149.33M
May 31, 2025	145.23M
February 28, 2025	143.58M
November 30, 2024	143.56M
August 31, 2024	142.34M
May 31, 2024	143.98M
February 29, 2024	145.48M
November 30, 2023	143.74M
August 31, 2023	145.83M
May 31, 2023	144.25M
February 28, 2023	145.67M
November 30, 2022	140.56M
August 31, 2022	137.01M
May 31, 2022	133.75M
February 28, 2022	128.77M
November 30, 2021	128.24M
August 31, 2021	124.35M
May 31, 2021	117.22M
February 28, 2021	110.70M
November 30, 2020	113.22M
August 31, 2020	114.93M
May 31, 2020	116.50M

Date	Value
February 29, 2020	119.34M
November 30, 2019	115.31M
August 31, 2019	112.72M
May 31, 2019	111.73M
February 28, 2019	110.18M
November 30, 2018	108.81M
August 31, 2018	106.80M
May 31, 2018	107.41M
February 28, 2018	108.49M
November 30, 2017	109.23M
August 31, 2017	110.03M
May 31, 2017	110.22M
February 28, 2017	109.33M
November 30, 2016	110.72M
August 31, 2016	112.06M
May 31, 2016	112.40M
February 29, 2016	112.38M
November 30, 2015	110.79M
August 31, 2015	111.09M
May 31, 2015	110.49M
February 28, 2015	111.02M
November 30, 2014	111.68M
August 31, 2014	110.12M
May 31, 2014	109.22M
February 28, 2014	107.48M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years

Start Trial

--

Minimum

--

Maximum

--

Average

--

Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks

Start Trial

Boston Scientific Corp.	7.159B
Penumbra, Inc.	741.31M
Abbott Laboratories	13.94B
Alphatec Holdings, Inc.	524.06M
AtriCure, Inc.	323.68M